Abdelhamid AS, Brown TJ, Brainard JS et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2020; (2): CD003177
Cai T, Abel L, Langford O et al. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses. BMJ 2021; 374: n1537.
Chou R, Cantor A, Dana T et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force. 2022.
Curfman G. Omega-3 Fatty Acids and Atrial Fibrillation. JAMA 2021; 325(11): 1063.
De Souza RJ, Mente A, Maroleanu A et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 2015; 351: h3978.
Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM). Hausärztliche Risikoberatung zur kardiovaskulären Prävention (S3-Leitlinie, under revision). AWMF register no.: 053-024. 2021.
Hooper L, Al-Khudairy L, Abdelhamid AS et al. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2018; (11): CD011094.
Hooper L, Martin N, Jimoh OF et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev 2020; (8): CD011737.
Hu P, Dharmayat KI, Stevens CA et al. Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis. Circulation 2020; 141(22): 1742-1759.
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Screening for the early detection of familial hypercholesterolaemia in children and adolescents: Rapid report; Commission S24-01. 2024.
Mach F, Baigent C, Catapano AL et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41(1): 111-188.
Mihaylova B, Emberson J, Blackwell L et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012; 380(9841): 581-590.
National Cholesterol Education Program (NCEP). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-2497.
National Institute for Health and Care Excellence (NICE). Familial hypercholesterolaemia: identification and management (NICE Clinical Guidelines; No. 71). 2019.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.